![]() |
市場調查報告書
商品編碼
2032429
腹膜透析市場報告:按治療方法、產品類型、最終用戶和地區分類(2026-2034 年)Peritoneal Dialysis Market Report by Treatment Type (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis ), Product, End User, and Region 2026-2034 |
||||||
2025年,全球腹膜透析市場規模達188億美元。展望未來,IMARC Group預測,2026年至2034年間,該市場將以4.00%的複合年成長率成長,到2034年達到270億美元。北美地區是推動市場成長的主要力量,這得益於醫療基礎設施的改善、慢性腎臟病病患者數量的成長以及以患者為中心的家庭透析解決方案的日益普及。此外,全球透析中心數量的增加、政府主導的腎臟病管理推廣計劃的擴大、持續性攜帶式腹膜透析(CAPD)的普及以及開發中國家醫療基礎設施的完善,也共同推動了該市場的發展。
腹膜透析(PD)是一種治療方法腎衰竭的方法,透過手術將一根軟性塑膠管或導管植入腹膜或腹腔。植入後,無菌透析液經由此導管輸送,過濾血液中的代謝廢物。經過一段時間後,透析液和過濾後的代謝廢物從腹腔排放並丟棄。腹膜透析分為持續性攜帶式腹膜透析(CAPD)及持續性循環腹膜透析(CCPD)。這些技術提高了治療的柔軟性,減少了患者前往透析中心的次數,並改善了臨床療效,從而減少了藥物用量並放寬了飲食限制。此外,由於腹膜透析可以在家中進行且無需針頭,因此也被醫院和醫療中心用於治療腎衰竭。
意識提升並擴大教育活動
慢性腎臟病)治療方案的日益普及推動了腹膜透析市場的需求,促使患者傾向於選擇更便捷的居家治療。過去,由於患者對血液透析以外的替代療法缺乏了解,腹膜透析的普及率一直受到限制。然而,醫療專業人員、計劃團體和相關人員加強了教育力度,使患者能夠做出更明智的選擇。宣傳活動著重於腹膜透析的治療益處、生活方式的適應性和經濟性,使患者能夠積極參與治療決策。改良的訓練模組和易於取得的指導材料幫助患者及其看護者有效地進行居家治療,進一步增強了他們對這種治療方法治療方法的信心。隨著人們對腹膜透析長期安全性和益處的認知不斷加深,越來越多的人選擇它而非傳統療法。這種以知識為基礎的選擇正在提高整體接受度,提升患者滿意度,並使腹膜透析成為腎臟護理領域的首選治療方案。
對居家透析療法的支持日益成長
腹膜透析為患者提供了在家接受治療的便利,減少了他們去醫院的次數,並最大限度地減少了與醫療環境的接觸。這種自主性提高了患者的舒適度,增強了他們對治療方案的依從性,並最終改善了他們的生活品質。醫療專業人員和政策制定者正在推廣居家治療方案,以減輕透析機構的負擔,並促進醫療資源的合理利用。腹膜透析的柔軟性使患者能夠將治療融入日常生活,在確保臨床療效的同時,增強了患者的自主性。此外,培訓和患者支持措施的改進也使患者能夠更安全地進行自我治療。居家照護模式的日益普及與更廣泛的醫療服務趨勢相符,並推動了腹膜透析作為首選治療方案的進一步推廣。
支持性的政府政策與還款框架
世界各地的政策制定者都意識到腎臟疾病發病率不斷上升以及對永續治療方案的需求,因此致力於改善透析服務的可及性。腹膜透析的部分或全部報銷計劃可以減輕患者的經濟負擔,提高治療的成本效益,並促進其更廣泛的普及。作為這些努力的一部分,德里政府宣布計劃於2025年透過總理國家發展計畫(PMNDP)和公私合作(PPP)透析項目,在六家公立醫院安裝150台新的透析機。這將為低收入群體提供免費透析,並為其他族群提供補貼治療。這些措施加強了現有基礎設施,對於確保公平獲得治療至關重要。此外,相關部門正在進行宣傳和培訓活動,以增強患者和看護者對居家照護的信心。透過建立支持系統和提供獎勵,政策制定者正在提高腹膜透析的可及性,促進其廣泛應用,並推動市場的永續擴張。
糖尿病和高血壓盛行率增加
糖尿病和高血壓等慢性疾病的日益普及仍然是腹膜透析市場的重要促進因素,因為這些疾病是慢性腎臟病和末期腎功能衰竭的主要原因。隨著越來越多人面臨腎臟問題,對高效且方便的腎臟替代療法的需求也日益成長。根據國際糖尿病聯盟(IDF)發布的《糖尿病地圖集》(2025版),20至79歲成年人中,11.1%(約九分之一)患有糖尿病,其中超過40%的人對此毫不知情。這凸顯了未確診和未治療糖尿病的巨大風險。這種不斷成長的需求凸顯了腹膜透析等柔軟性治療方法的重要性,腹膜透析可以進行持續治療,並且可以在家中進行。其能夠靈活適應個人日程安排和生活方式的特點,對併發症患者尤為有利。在全球重視早期療育和慢性病管理的背景下,隨著糖尿病和高血壓盛行率的上升,腹膜透析的採用率也不斷提高。
人口老化的過程
全球人口老化對腹膜透析的普及產生了顯著影響。這是因為老年人罹患慢性腎臟病和末期腎功能衰竭的風險更高。由於行動不便和自我管理能力下降,老年人通常更適合居家照護。腹膜透析透過在非醫院環境下提供持續靈活的護理來滿足這些需求,從而減少對醫療機構的依賴。世界衛生組織(WHO)預測,到2030年,全球六分之一的人口將超過60歲,到2050年,這一數字預計將達到21億。此外,80歲及以上人口預計將增加三倍,達到4.26億。這些人口結構的變化推動了對便利性、微創且以患者為中心的解決方案的需求成長,這些解決方案旨在滿足老年人的需求。隨著全球預期壽命的延長,腹膜透析正成為提供有效腎臟護理的關鍵手段,預計將推動市場長期成長和進一步普及。
透析液配方方面的進展
腹膜透析液配方的進步透過提高患者安全性、舒適度和治療效果,促進了市場成長。現代透析液旨在增強生物相容性,最大限度地減少長期使用過程中的刺激,並維持腹膜功能。改良的配方還能減少感染疾病和發炎等問題,進而提高患者的治療順從性。此外,葡萄糖衍生物、胺基酸和艾考糊精配方的進步提高了超濾效率,並為患者帶來更佳的代謝結果。這些進步使得個人化治療成為可能,可以根據患者的個別需求客製化治療方案,同時確保療效的穩定性。因此,先進且易於使用的透析方案的開發正在提高腹膜透析的接受度,改善治療效果,並提升患者的長期滿意度。因此,透析液化學成分和給藥機制的持續進步是支撐市場成長的關鍵因素。
The global peritoneal dialysis market size reached USD 18.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 27.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.00% during 2026-2034. North America leads the market attributed to improved healthcare infrastructure, rising cases of chronic kidney diseases, and increasing adoption of home-based dialysis solutions supporting patient-centered care. The market is being driven by the rising number of dialysis centers worldwide, the increasing government initiatives to promote kidney disease management, the growing adoption of continuous ambulatory peritoneal dialysis (CAPD), and the expanding healthcare infrastructure in developing countries.
Peritoneal dialysis (PD) represents a type of kidney failure treatment procedure wherein a soft plastic tube or catheter is placed in the abdominal lining or belly through surgery. Once it is positioned, a sterile cleansing fluid is transmitted by the duct that helps filter the blood inside an individual's body by removing waste products. After a period of time, the liquid and filtered unwanted components flow out of the abdomen and are discarded. PD is differentiated into continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis (CCPD). These approaches offer treatment flexibility, reduce the need to visit dialysis centers, and provide better clinical outcomes, resulting in lesser medications and fewer food restrictions. Apart from this, it can be carried out at home and is needle-free; thus, PD is used by hospitals and healthcare centers to treat kidney failures.
Expanding Patient Awareness and Education Initiatives
Increasing awareness about treatment choices for chronic kidney disease is driving the peritoneal dialysis market demand by promoting patient preference for accessible and home-based care. Historically, a lack of patient awareness regarding alternatives to hemodialysis restricted adoption rates. Nonetheless, enhanced educational efforts by healthcare professionals, advocacy organizations, and industry stakeholders are assisting patients in making more informed choices. Awareness initiatives emphasize the therapeutic benefits, lifestyle adaptability, and financial savings linked to peritoneal dialysis, enabling patients to engage actively in their care decisions. Improved training modules and accessible instructional materials enable patients and caregivers to effectively handle the therapy at home, further boosting their confidence in the treatment method. As knowledge about the long-term safety and benefits of peritoneal dialysis grows, an increasing number of people are opting for this treatment instead of traditional alternatives. This movement toward knowledge-based choices is enhancing overall acceptance, improving patient satisfaction, and establishing peritoneal dialysis as a favored treatment option in kidney care.
Growing Preference for Home-Based Dialysis Therapies
Peritoneal dialysis provides patients the ease of performing treatment at home, lowering reliance on hospital appointments and decreasing exposure to medical environments. This independence boosts patient comfort, increases compliance with treatment plans, and leads to an improved overall quality of life. Healthcare professionals and policymakers are promoting home-based options to alleviate strain on dialysis facilities and enhance healthcare resource utilization. The adaptability of peritoneal dialysis enables patients to incorporate treatment into their everyday lives, fostering autonomy while ensuring clinical efficacy. Moreover, improvements in training and patient assistance initiatives are facilitating safer self-management of treatments for individuals. The increasing acceptance of home-based care models corresponds with wider trends in healthcare delivery, encouraging further adoption of peritoneal dialysis as a favored treatment choice.
Supportive Government Policies and Reimbursement Frameworks
Policymakers worldwide are recognizing the growing occurrence of kidney diseases and the need for sustainable treatment solutions, resulting in efforts to enhance dialysis access. Reimbursement programs for peritoneal dialysis, either partial or complete, alleviate financial pressures on patients, making treatment more cost-effective and promoting wider acceptance. As part of these initiatives, in 2025, the Delhi government unveiled plans to introduce 150 new dialysis machines across six government hospitals through the PMNDP and PPP Dialysis Project, offering complimentary dialysis for low-income groups and subsidized treatment for others. Such initiatives enhance current infrastructure and are vital for guaranteeing equitable access to treatment. Additionally, authorities are promoting awareness initiatives and training activities to enhance the confidence of patients and caregivers in home-based treatments. Through the establishment of supportive structures and the provision of incentives, policymakers are enhancing the availability of peritoneal dialysis, promoting its adoption, and serving as a driving force for lasting market expansion.
Increasing Prevalence of Diabetes and Hypertension
The rising incidence of chronic diseases like diabetes and hypertension continues to be a significant factor in the peritoneal dialysis market, as these conditions are primary contributors to chronic kidney disease and end-stage renal failure. As more people face kidney issues, the need for efficient and easily accessible kidney replacement treatments keeps growing. As per the International Diabetes Federation (IDF) Diabetes Atlas (2025), 11.1% of adults between 20 and 79-about 1 in 9-are affected by diabetes, with over 40% unaware of their status, highlighting the critical issue of undiagnosed and unaddressed risks. This growing demand underscores the significance of scalable treatment options like peritoneal dialysis, which offers ongoing therapy and can be administered at home. Its capacity to accommodate personalized schedules and lifestyle adaptability is particularly beneficial for patients with comorbid conditions. With a global emphasis on early intervention and managing chronic diseases, the growing prevalence of diabetes and hypertension are leading to higher adoption of peritoneal dialysis.
Rising Geriatric Population
The growing global elderly population significantly influences the adoption of peritoneal dialysis, as older adults are at greater risk for chronic kidney disease and end-stage renal failure. Elderly individuals frequently gain from home treatments as a result of limited mobility and the ease of self-delivered care. Peritoneal dialysis meets these demands by providing ongoing and adaptable care outside of hospital environments, thus reducing reliance on healthcare facilities. The World Health Organization (WHO) states that by 2030, one in every six individuals globally will be 60 years old or more, and this number is anticipated to hit 2.1 billion by 2050, with those over 80 expected to increase threefold to 426 million. This population change increases the need for accessible, minimally invasive, and patient-focused solutions designed for elderly requirements. With global life expectancy increasing, peritoneal dialysis is set to become essential for providing effective kidney care, fostering long-term market growth and greater acceptance.
Advancements in Dialysis Solution Formulations
Advancements in peritoneal dialysis solution formulations are contributing to the market growth by improving patient safety, comfort, and treatment effectiveness. Contemporary solutions aim to enhance biocompatibility, minimizing irritation and maintaining peritoneal membrane function during extended use. Enhanced formulations also reduce issues like infection or inflammation, boosting patient compliance with treatment. Furthermore, advancements in glucose-derived, amino acid, and icodextrin solutions provide enhanced ultrafiltration effectiveness and superior metabolic results for patients. These developments enable customized therapy, permitting treatment plans to be adjusted to specific patient requirements while ensuring steady effectiveness. As a result, the creation of sophisticated, user-friendly dialysis options promotes greater acceptance of peritoneal dialysis, improves treatment results, and boosts long-term patient contentment. Ongoing advancements in solution chemistry and delivery mechanisms are thus a vital factor bolstering the market growth.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.